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Although previous studies have proposed plausible mechanisms of the activation of transforming growth factor-b-activated
kinase 1 (TAK1) in inﬂammatory signals, including Toll-like receptors (TLRs), its activating kinase still remains to be unclear.
In the present study, we have provided evidences that AMP-activated protein kinase (AMPK)-a1 has a pivotal role for activating
TAK1, and thereby regulate NF-jB-dependent gene expressions in inﬂammatory signaling mediated by TLR4 and TNF-a
stimulation. AMPK-a1 speciﬁcally interacts with TAK1 and reciprocally regulates their kinase activities. Upon the stimulation of
lipopolysaccharide, AMPK-a1-knockdown (AMPK-a1
KD) or TAK1-knockdown human monocytic THP-1 cells exhibit a dramatic
reduction in the TAK1 or AMPK-a1 kinase activity, respectively, and subsequent suppressions of its downstream signaling
cascades, which further leads to inhibitions of NF-jB and thereby productions of proinﬂammatory cytokines, such as TNF-a,
IL-1b, and IL-6. Importantly, the microarray analysis of AMPK-a1
KD cells revealed a dramatic reduction in the NF-jB-dependent
genes induced by TLR4 and TNF-a stimulation, and the observation was in signiﬁcant correlation with the results of quantitative
real-time PCR. Moreover, AMPK-a1
KD cells are highly sensitive to the TNF-a-induced apoptosis, which is accompanied with
dramatic reductions in the NF-jB-dependent and anti-apoptotic genes. As a result, our data demonstrate that AMPK-a1a sa n
activating kinase of TAK1 has a key role in mediating inﬂammatory signals triggered by TLR4 and TNF-a.
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Transforming growth factor-b (TGF-b)-activated kinase 1
(TAK1) is a member of the mitogen-activated protein kinase
kinase kinase family and a serine/threonine protein kinase.
1–4
TAK1 functions as an upstream signaling molecule of NF-kB
and MAPKs in proinﬂammatory signals transduced by TNF-a,
IL-1b, and Toll-like receptor (TLR) ligands.
5,6 Binding
of lipopolysaccharide (LPS) to TLR4 causes recruitment of
MyD88, IRAK, and TRAF6 to the receptor.
7,8 The TRAF6
catalyzes synthesis of K63-linked polyubiquitin chains that
serve as a scaffold to recruit the TAK1 and IkB kinase (IKK)
complexes. Recruitment of the kinase complexes facilitates
autophosphorylation of TAK1 and subsequent phosphoryla-
tion of IKKb by TAK1, leading to IkB degradation and
subsequent activation of NF-kB.
5,6 Despite of the plausible
mechanisms by which TAK1 is activated,
6 the existence of a
speciﬁc upstream kinase of TAK1 in the signaling cascades
is still ambiguous.
The AMP-activated protein kinase (AMPK) is a serine/
threonineproteinkinasethathasemergedasa mastersensor
of cellular energy balance in mammalian cells.
9,10 The AMPK
protein exists as a heterotrimer composed of a 63-kDa
catalytic (a) subunit and two non-catalytic regulatory subunits,
b (30kDa) and g (38–63kDa). There are several isoforms for
each of the three AMPK subunits, including a1, a2, b1, b2, g1,
g2, and g3.
11,12 The two AMPKa variants, a1 and a2, have
been shown to have a differential localization pattern in
mammalian cells, with theAMPK-a1 subunit being localized in
the cytoplasm, whereas the AMPK-a2 subunit localized in the
nucleus.
13,14 In terms of cell type speciﬁcity, most of the cells
express both AMPK-a1 and AMPK-a2 isoforms, whereas
lymphcytes only express the AMPK-a1 isoform.
15,16 A
previousreport hasaddressedtherelationshipbetweenT-cell
receptor-mediated signaling and AMPK-a1 through Ca
2þ-
calmodulin-dependent protein kinase (CaMKK)-dependent
pathway, implying that AMPK-a1 may have speciﬁc roles in
immune cells.
15
Here, we demonstrate that AMPK-a1 has a pivotal role in
inducing proinﬂammatory signals, such as TLR4 and TNF-a,
through the activation of TAK1. The knockdown of AMPK-a1
results in the marked reduction of TAK1 activity, and thereby
suppressions of downstream signaling cascades and the
expression of NF-kB-dependent genes in response to LPS
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TLR4-mediated signaling. Moreover, AMPK-a1-knockdown
cells are highly sensitive to TNF-a-induced apoptosis,
supporting the functional role of AMPK-a1 associated
with expressions of anti-apoptotic genes regulated by the
TAK1-induced NF-kB activity. Thus, our results suggest that
AMPK-a1 may be one of the upstream kinases capable
of inducing the activation of TAK1 in proinﬂammatory signals.
Results
Inhibition of AMPK-a1 activity attenuates TLR4-mediated
signaling pathway. Previous reports have demonstrated
the functional relationship between AMPK and TAK1;
17–20
however, the functional role of AMPK-a1 has not yet been
elucidated in innate signal. Therefore, we have explored this
issue in human monocytic THP-1 cells with a TLR4 agonist,
LPS. To know whether LPS stimulation induces the activa-
tion of AMPK-a1, because it has been known that AMPK-a1,
but not AMPK-a2, is solely expressed in human monocytic
cells,
16 THP-1 cells were treated with LPS for different time
intervals and then the activation of AMPK-a1 was evaluated
with anti-pho-AMPK antibody. The phosphorylation
of AMPK-a1 was gradually increased by LPS treatment in a
time-dependent manner (Supplementary Figure 1). To
further examine whether AMPK-a1 is either a positive or
negative regulator in the TLR4-mediated signaling pathway,
leading to activate NF-kB and activator protein 1 (AP-1),
THP-1 cells were stimulated with LPS in the presence or
absence of different concentrations of compound C, which is
a pharmacological inhibitor of AMPK.
21 Both NF-kB and
AP-1 reporter activities induced by LPS were signiﬁcantly
reduced in compound C-treated THP-1 in a dose-dependent
manner (Figure 1a, NF-kB; Figure 1b, AP-1). Furthermore,
the inhibition of AMPK-a1 activity resulted in a dramatic
reduction in the levels of proinﬂammatory cytokines, such as
TNF-a, IL-6, and IL-1b, induced by LPS (Figure 1c, IL-6;
Figure 1d, TNF-a; Figure 1e, IL-1b). We next attempted to
verify the speciﬁc function of AMPK-a1 in terms of its kinase
activity. For this, we constructed dominant negative (DN),
AMPK-a1 (D159A), and constitutive active (CA), AMPK-a1
(T174D), forms of AMPK-a1, and examined their functional
roles (Figure 1f). Overexpression of wild-type (wt) AMPK-a1
slightly enhanced the activities of both, NF-kB and AP-1, in
the presence or absence of LPS stimulations (Figures 1g
and h, closed bar), whereas AMPK-a1 (D159A) DN
signiﬁcantly suppressed these activities (Figures 1g and h,
chute-block bar). In contrast, AMPK-a1 (T174D) CA induced
increase in the activities of NF-kB and AP-1 (Figures 1g and
h, hatched bar). Consistent with the above-mentioned
ﬁndings, similar results in the production of inﬂammatory
cytokines were observed (Figure 1i, TNF-a; Figure 1j, IL-6;
Figure 1k, IL-1b). These results suggest that AMPK-a1 may
be positively involved in TLR4-mediated signaling pathway.
The autoinhibitory domain of AMPK-a1 interacts with
N-terminus of TAK1, and that reciprocally regulate their
activations. We next explored the molecular mechanism by
which AMPK-a1 is involved in TLR4-mediated signaling.
Previous reports have shown that TAK1 is involved in
the activation of AMPK.
17–20 We raised a possibility of the
functional regulation between TAK1 and AMPK-a1 serine/
threonine protein kinase. We ﬁrst tested the molecular
interaction between AMPK-a1 and TAK1. The overexpressed
TAK1 was signiﬁcantly co-immunoprecipitated with over-
expressed AMPK-a1, and the interaction was enhanced by
LPS stimulation (Figure 2a, lane 4 versus lane 5). To identify
the interaction domain in each other, TAK1 or AMPK-a1
truncated mutants were constructed (Supplementary
Figure 2), and then immunoprecipitation assay was per-
formed. Overexpressed AMPK-a1 was speciﬁcally co-immu-
noprecipitated with all the truncated TAK1 construct,
indicating that AMPK-a1 interacts with TAK1 through the
N-terminus of TAK1 (Figure 2b). In addition, TAK1 speciﬁ-
cally interacted with the autoinhibitory domain of AMPK-a1,
AMPK-a1 (312–392) (Figure 2c). To verify the in vitro
interaction, we further performed endogenous immunopreci-
pication assay. Consistent with in vitro interaction, endogen-
ous TAK1 was speciﬁcally coprecipitated with endogenous
AMPK-a1, and the interaction was signiﬁcantly enhanced in
response to LPS stimulation (Figure 2d, lane 1 versus
lane 2). These results suggest that the autoinhibitory domain
of AMPK-a1 interacts with the N-terminus of TAK1
(Figure 2e). We next explored whether AMPK-a1 is directly
able to activate TAK1 in response to LPS stimulation.
To ﬁnd an answer for our query, we generated knockdown
THP-1 cells against AMPK-a1 and TAK1 protein by using
siRNA-contained lentiviruses (Supplementary Figure 3 and
Figure 2f). Interestingly, phosphorylations of Thr172/174
and Ser 485 of APK-a1 were markedly reduced and
the phosphorylation of TAK1 was dramatically reduced in
AMPK-a1-knockdown (AMPK-a1
KD) THP-1 cells treated with
LPS as compared with that of wt THP-1 cells (Figure 2f,
AMPK-a1
KD). Interestingly, TAK1-knockdown (TAK1
KD) cells
exhibited marked reduction in phosphorylation of Thr172/174
and Ser 485 of AMPK-a1 in response to LPS stimulation
(Figure 2f, TAK1
KD). It was partly consistent with the
previous report that TAK1 is involved in the activation of
AMPK-a1.
17 Consistent with the result, the kinase activity
of TAK1 or AMPK-a1 induced by LPS stimulation was
also signiﬁcantly reduced in AMPK-a1
KD or TAK1
KD THP-1
cells, respectively, as compared with that of wt THP-1 cells
(Figure 2g, TAK1; Figure 2h, AMPK-a1). These results
strongly demonstrate that the autoinhibitory domain of
AMPK-a1 interacts with N-terminus of TAK1, which further
reciprocally regulates their kinase activities (Figure 2e).
AMPK-a1-knockdown THP-1 cells exhibit the impair-
ments of TLR4-mediated signaling pathway. To under-
stand the functional role played by AMPK-a1 in TLR4-
mediated signaling pathway, biochemical studies were
performed in AMPK-a1
KD THP-1 cells. Basal activities of
NF-kB and AP-1 were signiﬁcantly decreased in AMPK-a1
KD
THP-1 cells, as compared with that of wt THP-1 cells
(Figures 3a and b, closed bars). Their activity were markedly
increased in LPS-treated wt THP-1 cells (Figures 3a and b,
doted bars), moreover, signiﬁcantly enhanced in wt-AMPK-
a1-expressed wt THP-1 stimulated with LPS, as compared
with that of unstimulated wt THP-1 cells (Figures 3a and b,
chute-block bar). To gain further direct evidence on whether
AMPK-a1 as an activating kinase of TAK1
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Cell Death and DiseaseAMPK-a1 is involved in the TLR4-mediated signal, we
performed the rescue experiment in AMPK-a1
KD THP-1
cells. The wt AMPK-a1 vector was transfected in the AMPK-
a1
KD THP-1 cells. The AMPK-a1
KD THP-1 cells transfected
with AMPK-a1 vector were treated with or without LPS.
Interestingly, the activities of NF-kB and AP-1 were markedly
recovered, as compared with that of mock transfectant
AMPK-a1
KD THP-1 cells treated with LPS (Figures 3a and b
Figure 1 Inhibition of AMPK-a1 activity attenuates TLR4-signaling pathway. (a and b) The THP-1 cells were transfected with either pBIIx-Luc (a) or AP-1-luc (b) together
with Renilla luciferase vector. At 24h after transfection, cells were treated with or without LPS (10ng/ml) for 6h in the presence or absence of different concentrations of
compoundCasindicated,andthenanalyzedforluciferaseactivity.Resultsareexpressedasthefoldinductioninluciferaseactivityrelativetothatofuntreatedcells.Errorbars
indicate ±S.D. of triplicate samples. (c–e) The THP-1 cells were treated with or without LPS (10ng/ml) for 9h in the presence or absence of different concentrations of
compoundC as indicated,and then analyzedfor productionsof IL-6(c), TNF-a (d), and IL-1b (e) in supernatants usingELISA method. Error bars indicate ±S.D. of triplicate
samples. (f) The AMPK-a1 (D159A) and AMPK-a1 (T174D) mutants were generated by site-directed mutagenesis as described in Materials and Methods. (g and h) The
THP-1 cells were transfected with mock, wt (wt) hAMPK-a1, DN hAMPK-a1 D159A, or constitutive active (CA) hAMPK-a1 T174D vector. At 24h after transfection, cells were
transfected with either pBIIx-Luc (g) or AP-1-luc (h) together with Renilla luciferase vector. After 24h, cells were treated with or without LPS (10ng/ml), and then analyzed for
luciferase activity. Results are expressed as the fold induction in luciferase activity relative to that of untreated cells. Error bars indicate ±S.D. of triplicate samples. (i–k) The
THP-1 cells were transfected with mock, wt hAMPK-a1, DN hAMPK-a1 D159A, or CA hAMPK-a1 T174D vector. At 24h after transfection, cells were treated with or without
LPS (10ng/ml) for 9h, and then analyzed for productions of TNF-a (i), IL-6 (j), and IL-1b (k) in supernatants using ELISA method. Error bars indicate ±S.D. of triplicate
samples. *Po0.05, **Po0.01, NS, not signiﬁcant
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Cell Death and Diseasein AMPK-a1
KD, dotted bar versus chute-block bar). Given
these results, we further assessed DNA-binding activities of
NF-kB, p65 and p50, and AP-1, c-fos and c-jun. Consistently,
overexpressions of AMPK-a1 in wt THP-1 markedly
enhanced DNA-binding activities of p65, p50, c-fos, and
c-jun (Figure 3c, p65; Figure 3d, p50; Figure 3e, c-fos;
Figure 3f, c-jun). Furthermore, these DNA-binding activities
were signiﬁcantly increased in AMPK-a1-transfected AMPK-
a1
KD THP-1 cells (Figure 3c, p65; Figure 3d, p50; Figure 3e,
c-fos; Figure 3f, c-jun), indicating a positive role of AMPK-a1
in TLR4-mediated signaling. Based on the functional role of
AMPK-a1 in TLR4-mediated activations of NF-kB and AP-1,
we next assessed regulations of signaling molecules, which
appear in the TLR4-mediated signaling cascades. For this,
wt THP-1 and AMPK-a1
KD THP-1 cells were treated with
or without LPS for different times. As expected, the
phosphorylation of TAK1 was markedly attenuated in
AMPK-a1
KD THP-1 cells, as compared with that of wt
THP-1 cells (Figure 3g, pho-TAK1). Interestingly, phosphor-
ylations of other downstream signaling molecules, such as
p-38, JNK, and AKT, were also signiﬁcantly decreased in
AMPK-a1
KD THP-1 cells (Figure 3g). These results were
partly consistent with previous reports that AMPK has an
important role in promoting activations of p38 MAPK, JNK,
and AKT.
22–24 Moreover, we found that a marked reduction
of proinﬂammatory cytokines, such as TNF-a, IL-1b, and
IL-6, induced by LPS stimulation could be detected in
AMPK-a1
KD THP-1 cells, as compared with that of wt
THP-1 cells (Figure 3h). These results provide evidence on
the positive role of AMPK-a1 in TLR4-mediated signaling
pathway through the activation of TAK1.
AMPK-a1-knockdown THP-1 cells exhibit the impair-
ments of expression of NF-kB-dependent genes induced
by TLR4. To validate the axis of AMPK-a1-TAK1-NF-kBi n
TLR4-mediated signaling pathway in a detailed manner, we
Figure 2 Molecular interaction between AMPK-a1 and TAK1. (a) The HEK293 cells were transfected with Myc-TAK1, Flag-AMPK-a1, or Myc-TAK1 and Flag-AMPK-a1
vector. At 36h after transfection, cells were treated with or without LPS (100ng/ml) for 45min. The cells were extracted and immunoprecipitated with anti-Myc antibody. The
interactionwasdetectedbywesternblottingwithanti-Flagantibody.ThepresenceofMyc-TAK1andFlag-AMPK-a1inthepre-IPlysateswasveriﬁedbywesternblotanalysis.
(b) The HEK293 cells were transfected with Flag-AMPK-a1 and wt Myc-TAK1, Flag-AMPK-a1 and Myc-TAK1 (1–500), Flag-AMPK-a1 and Myc-TAK1 (1–400), Flag-AMPK-a1
and Myc-TAK1 (1–300), Flag-AMPK-a1 and Myc-TAK1 (1–200), or Flag-AMPK-a1 and Myc-TAK1 (1–100) vectors. At 36h after transfection, transfected cells were extracted
andimmunoprecipitatedwithanti-Flagantibody.Theinteractionwasdetectedbywesternblottingwithanti-Mycantibody.ThepresenceofMyc-TAK1mutantsandFlag-AMPK-a1
inthepre-IPlysateswas veriﬁed bywestern blotanalysis.(c)The HEK293 cellswere transfected withMyc-TAK1andwtFlag-AMPK-a1,Myc-TAK1andFlag-AMPK-a1 (1–312),
or Myc-TAK1 and Flag-AMPK-a1 (1–392). At 36h after transfection, transfected cells were extracted and immunoprecipitated with anti-Myc antibody. The interaction was
detected by western blotting with anti-Flag antibody. The presence of Flag-AMPK-a1 mutants and Myc-TAK1 in the pre-IP lysates was veriﬁed by western blot analysis.
(d) The THP-1 cells were treated with or without LPS (100ng/ml) for 45min. Cells were extracted and immunoprecipitated with anti-TAK1 antibody. The interaction was
detected by western blotting with anti-AMPK-a1 antibody. The presence of TAK1 in the pre-IP lysates was veriﬁed by western blot analysis. (e) A model of molecular interaction
between AMPK-a1 and TAK1. Above results suggest the molecular interaction between the autoinhibitory domain of AMPK-a1 and the N-terminus of TAK1. (f) WT THP-1,
AMPK-a1
KD, and TAK-1
KD THP-1 cells were treated with or without LPS (10ng/ml) for different times as indicated. Cell lysates were subjected to western blot analysis using
the indicated antibodies. (g and h) WT THP-1, AMPK-a1
KD, and TAK-1
KD THP-1 cells were treated with or without LPS (10ng/ml) for different times as indicated. In vitro
kinase assay for TAK1 (g) and AMPK-a1( h) was performed as described in Materials and Methods. Error bars indicate ±S.D. of triplicate samples. *Po0.05, **Po0.01
AMPK-a1 as an activating kinase of TAK1
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Cell Death and Diseaseperformed gene expression analysis. According to stimula-
tion of LPS, marked changes in gene expression proﬁles
could be detected (Supplementary Figure 4). To assess the
NF-kB-dependent gene expressions by LPS stimulation, 94
genes containing speciﬁc kB-binding DNA sequences were
further sorted out. Expression levels of 94 genes were
signiﬁcantly altered in either wt or AMPK-a1
KD THP-1 cells by
treatment with or without LPS (Figure 4a). According to
the relative up and down expressions in each combination,
36 genes were selected, and were subdivided into two
groups: group 1, highly regulated genes such as IL-1b, IL-8,
CD44, TNF-a, and CCL-5; and group 2, moderately regulated
genes such as NF-KB1, NF-KB1A, NF-KB1E, RELB,
IER3, REL, and BCL3 (Figure 4b, Supplementary Table 1a,
and Supplementary Table 1b). To verify their expression, we
performed quantitative real-time PCR (qRT-PCR) analysis
with speciﬁc primers targeted to each gene. Both group 1 and
group 2 genes were greatly upregulated in LPS-treated wt
THP-1 cells, as compared with that of without stimulation,
whereas minute changes could be detected in LPS-treated
AMPK-a1
KD THP-1 cells, as compared with that of without
stimulation (Figure 4c, group 1 gene; Figure 4d, group
2 gene). These results strongly support that AMPK-a1i s
positively involved in the TLR4-mediated signaling pathway
through the activation of TAK1, and thereby regulates
TLR4-mediated NF-kB-dependent gene expression.
AMPK-a1 is functionally involved in TNF-a-induced
apoptosis through the regulation of NF-kB-dependent
genes. Previous studies have shown that TAK1 has a
protective role against TNF-a-induced apoptosis through the
activation of NF-kB.
3,4 In addition, a recent report has shown
that AMPK confers protection against TNF-a-induced cardiac
cell death.
25 Based on these previous reports and our above
Figure 3 AMPK-a1-knockdown THP-1 cells exhibit impairments of TLR4-mediated signal, leading to activation of NF-kB and AP-1. (a and b) The wt THP-1 and AMPK-
a1
KD THP-1 cells were transfected with or without hAMPK-a1 vector. Twenty-four hours after transfection, cells were transfected with either pBIIx-Luc (a) or AP-1-luc (b)
together with Renilla luciferase vector. After 24h, cells were treated with or without LPS (10ng/ml) for 6h, and then analyzed for luciferase activity. Results are expressed as
thefold inductionin luciferaseactivity relativeto thatof untreated cells. Error bars indicate ±S.D.of triplicatesamples.(c–f) Thewt THP-1 and AMPK-a1
KD THP-1 cellswere
transfectedwithorwithouthAMPK-a1vector.Twenty-fourhoursaftertransfection,cellsweretreatedwithorwithoutLPS(10ng/ml)for1h,andthenanalyzedforDNA-binding
activities for NF-KB, p65 (c) and p50 (d), and AP-1, c-Fos (e) and c-Jun (f), components as described in Materials and Methods. Results are expressed as the fold increase
relative to that of wt THP-1 transfected with mock. Error bars indicate ±S.D. of triplicate samples. (g) The wt THP-1 and AMPK-a1-knockdown (AMPK-a1
KD) THP-1 cells
weretreatedwithorwithoutLPS(10ng/ml)fordifferenttimesasindicated.Thelysateswereexaminedbywesternblottingwithanti-pho-TAK1,anti-TAK1,anti-IkBa,anti-pho-
p38,anti-p38,anti-pho-JNK,anti-JNK,anti-pho-AKT,andanti-AKTantibodies.Immunoblottingwithanti-GAPDHantibodywasperformedtogenerateacontrolforgelloading.
(h) The wt THP-1 and AMPK-a1-knockdown (AMPK-a1
KD) THP-1 cells were treated with or without LPS (10ng/ml) for 9h, and then analyzed for productions of TNF-a, and
IL-1b, and IL-6 in supernatants using ELISA method. Error bars indicate ±S.D. of triplicate samples. *Po0.05, **Po0.01, ***Po0.001
AMPK-a1 as an activating kinase of TAK1
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Cell Death and DiseaseFigure 4 AMPK-a1-knockdown THP-1 cells exhibit a marked reduction in NF-kB-dependent genes in response to LPS stimulation. (A) The wt THP-1 and AMPK-a1
KD THP-1
cells were treated with or without LPS (100ng/ml) for 3h. Total RNAs were isolated from each sample and microarray analysis was performed as described in Materials and Methods.
T h e9 6N F - kB-dependent upregulated and downregulated genes were sorted and represented: a, wt THP-1 cells treated with LPS versus wt THP-1 cells; b, AMPK-a1
KD THP-1 cells
treatedwithLPSversus AMPK-a1
KD THP-1 cells;c,AMPK-a1
KDTHP-1cellsversuswtTHP-1cells;andd,AMPK-a1
KD THP-1 cellstreatedwithLPSversuswtTHP-1cellstreatedwith
LPS.(B)Among96NF-kB-dependentgenes,36geneswerefurtherselectedandtheirexpressionpatternswererepresented.*,moderatelyregulatedgenes;**,highlyregulatedgenes.
(C) The WT THP-1 and AMPK-a1
KD THP-1 cells were treated with or without LPS (100ng/ml) for 3h. Total RNAs were isolated from each sample and quantitative RT-PCR
analysis was performed with speciﬁc primers targeted to IL-8, TNF, IL-1b, CD44, and CCL5 genes. Error bars represent mean±S.D. of triplicate samples. (D) The wt THP-1
and AMPK-a1
KD THP-1 cells were treated with or without LPS (100ng/ml) for 3h. Total RNAs were isolated from each sample and quantitative RT-PCR analysis was
performed with speciﬁc primers targeted to NF-KB1, NF-KB1A, NF-KB1E, RELB, IER3, REL, and BCL3 genes. Error bars represent mean±S.D. of triplicate samples
Figure 5 AMPK-a1-knockdown THP-1 cells are highly sensitive to TNF-a-induced apoptosis. (a and b) TAK1
 /  MEF cells were transfected with mock or Myc-TAK1
vector.At24haftertrasnfection,cellsweretreatedwithout(a)orwith(b)TNF-a(100ng/ml)for24h,andthenstainedwithBDCycletestPlus-DNAreagentinaccordancewith
the manufacturer’s protocol. The stained cells were analyzed with FACSCalibur system and apoptotic cell death was determined with Modﬁt LT 3.0 software. Error bars
representmean±S.D.of three independent experiments.(c andd)Thewt THP-1 (c)and AMPK-a1
KD THP-1cells(d) werecultured with culturemediumcontaining2% FBS
for 24h, and then treated with or without TNF-a (100ng/ml) for different times, as indicated. Cells were harvested and stained with FITC Annexin V Apoptosis Detection Kit
(BD Biosciences) in accordance with the manufacturer’s protocol. Samples were analyzed with FACSCalibur system and apoptotic cells were determined with CellQuest
software.Errorbarsrepresentmean±S.D.ofthreeindependentexperiments.(e–g)ThewtTHP-1andAMPK-a1
KDTHP-1cellswereculturedwithculturemediumcontaining
2%FBSfor24h,andthentreatedwithorwithoutTNF-a(100ng/ml)fordifferenttimes,asindicated.Caspase-3(e),caspase-8(f),andcaspase-9(g)activitiesweremeasured
using the CaspACE kit according to the manufacture’s instructions. Error bars represent mean±S.D. of three independent experiments. *Po0.01. (h) The genomic DNA
extracts were prepared as described in Materials and Methods, run on 1.8% agarose gels, and visualized under UV illumination
AMPK-a1 as an activating kinase of TAK1
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Cell Death and Diseaseresults, we assumed that, if AMPK-a1 has a key role in the
activation of TAK1, and thereby regulates the expression of
NF-kB-dependent genes, the defectiveness of AMPK-a1
might be critically affected on TNF-a-induced apoptosis. As
expected, apoptotic cell death induced by TNF-a was
markedly increased in TAK1
 / MEF cells (Figures 5a
and b, 9±2% in mock without TNF-a versus 23±4% in
mock with TNF-a), whereas the apoptosis was signiﬁcantly
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Cell Death and Diseasedecreased in TAK1-overexpressed TAK1
 / MEF cells than
in the case of mock transfectants (Figure 5b, 23±4% in
mock with TNF-a versus 10±3% in TAK1 with TNF-a).
Interestingly, AMPK-a1
KD THP-1 cells were highly sensitive
to TNF-a-induced apoptosis in a time-dependent manner as
compared with that of wt THP-1 cells (Figure 5c, wt THP-1;
Figure 5d, AMPK-a1
KD). To verify the results, we performed
caspase activity and DNA laddering assay in the same
condition. Consistently, the activities of caspase 3, caspase
9, and caspase 8 were markedly higher in AMPK-a1
KD THP-
1 cells than that in wt THP-1 cells activities (Figure 5e,
caspase 3; Figure 5f, caspase 9; Figure 5g, caspase 8).
Moreover, similar results could be seen in DNA laddering
assay (Figure 5h). These results suggest that AMPK-a1i s
functionally involved in TNF-a-induced apoptosis through the
regulation of TAK1 activity.
TNF-a signaling is transduced through its receptors to
simultaneously elicit two opposing effects: the induction of
apoptosis and the transcription of anti-apoptotic genes.
26,27
We therefore examined whether the effects of AMPK-a1o n
TNF-a-induced apoptosis are linked to the expression of
NF-kB-dependent genes and pro-apoptotic or anti-apoptotic
genes; we performed gene expression analysis of wt and
AMPK-a1
KD THP-1 cells with or without TNF-a stimulation,
respectively. According to stimulation of TNF-a, marked
changes in gene expression proﬁles could be detected
(Supplementary Figure 5). When we compared gene-expres-
sion proﬁles related to NF-kB-dependent genes, marked
changes could also be observed (Figure 6a, Supplementary
Table 2a and Supplementary Table 2b). qRT-PCR analysis
demonstrated that ﬁve different genes such as IL-1b, IL-8,
TNF-a, CCL5, and CD44 were greatly upregulated in TNF-a-
treated wt THP-1 cells as compared with that of without
stimulation, whereas minute changes could be detected in
TNF-a-treated AMPK-a1
KD THP-1 cells, as compared with
that of without stimulation (Figure 6b). Similar results could
also be detected in qRT-PCR analysis of NF-KB1A, NF-
KB1A, NF-B1E, REL, BCL3, and IER3 (Supplementary
Figure 6), indicating that AMPK-a1 is functionally related to
the expression of NF-kB-dependent genes in response to
TNF-a stimulation.
Suppression of AMPK-a1 is associated with the expres-
sion of pro- or anti-apoptotic genes in response to TNF-a
stimulation. We further assessed whether the sensitivity on
TNF-a-induced apoptosis in AMPK-a1
KD cells is associated
with the gene expression proﬁles related to apoptosis.
According to stimulation of TNF-a, marked changes in both
pro-apoptotic and anti-apoptotic gene expression proﬁles
could be detected (Figure 7a, Supplementary Tables 3a, 3b
and 4a, 4b). To verify these gene expression proﬁles, we
selected four different pro-apoptotic genes, such as PTEN,
LTA, MAGED1, and TNFRFS21, and four different anti-
apoptotic genes, such as SGK1, PI3KCB, BCL2L2, and
BCL2, and performed qRT-PCR analysis. The pro-apoptotic
genes were markedly increased in AMPK-a1
KD cells non-
treated with TNF-a, as compared with that of wt THP-1 cells
(Figure 7b, AMPK-a1
KD versus wt THP-1 in the group
without stimulation of TNF-a). According to stimulation of
TNF-a, moreover, two of them, PTEN and LTA, were
Figure 6 AMPK-a1-knockdown THP-1 cells exhibit a marked reduction in
NF-kB-dependent genes in response to TNF-a stimulation. (A) The wt THP-1 and
AMPK-a1
KD THP-1 cells were treated with or without TNF-a (100ng/ml) for 12h.
TotalRNAswereisolatedfromeachsampleandmicroarrayanalysiswasperformed
as described in Materials and Methods. The 96 NF-kB-dependent upregulated and
downregulated genes were sorted and represented: a, wt THP-1 cells treated with
TNF-aversuswtTHP-1cells;b,AMPK-a1
KDTHP-1cellstreatedwithTNF-aversus
AMPK-a1
KD THP-1 cells; c, AMPK-a1
KD THP-1 cells versus wt THP-1 cells; and d,
AMPK-a1
KD THP-1 cells treated with TNF-a versus wt THP-1 cells treated with
TNF-a.( B) The wt THP-1 and AMPK-a1
KD THP-1 cells were treated with or without
TNF-a (100ng/ml) for 12h. Total RNAs were isolated from each sample and
quantitative RT-PCR analysis was performed with speciﬁc primers targeted to IL-8,
TNF-a, IL-1b, CD44, and CCL5 genes. Error bars represent mean±S.D.
of triplicate samples
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Cell Death and Diseasesigniﬁcantly enhanced in AMPK-a1
KD cells (Figure 7b, upper
panels). The obtained result was critically consistent with
previous reports, which state that PTEN expression aug-
ments TNF-a-induced apoptosis through the inhibition of
NF-kB transcriptional activity.
28,29 In contrast, the anti-
apoptotic genes, such as SGK1, PI3KCB, and BCL2L2,
were signiﬁcantly enhanced by the stimulation of TNF-a in wt
THP-1 cells, whereas no signiﬁcant changes could be
Figure 7 TNF-a-induced apoptosis in AMPK-a1-knockdown THP-1 cells is associated with the expression of pro- or anti-apoptotic genes. (A) The wt THP-1 and AMPK-
a1
KDTHP-1cellsweretreatedwith orwithoutTNF-a(100ng/ml)for 12h. TotalRNAswereisolatedfromeachsampleandmicroarrayanalysiswasperformedasdescribedin
Materials and Methods. The pattern of pro-apoptotic and anti-apoptotic gene expression was represented; a, wt THP-1 treated with TNF-a versus wt THP-1; b, AMPK-a1
KD
THP-1 cells treated with TNF-a versus AMPK-a1
KD THP-1 cells; c, AMPK-a1
KD THP-1 cells versus wt THP-1; and d, AMPK-a1
KD THP-1 cells treated with TNF-a versus wt
THP-1 cells. (B) The wt THP-1 and AMPK-a1
KD THP-1 cells were treated with or without TNF-a (100ng/ml) for 12h. Total RNAs were isolated from each sample and
quantitative RT-PCR analysis was performed with speciﬁc primers targeted to pro-apoptotic genes such as PTEN, LTA, MAGED1, and TNFRFS21 genes. Error bars
representmean±S.D.oftriplicatesamples.(C)ThewtTHP-1andAMPK-a1
KDTHP-1cellsweretreatedwithorwithoutTNF-a(100ng/ml)for12h.TotalRNAswereisolated
fromeachsampleandquantitativeRT-PCRanalysiswasperformedwithspeciﬁcprimerstargetedtoanti-apoptoticgenessuchasSGK1,PI3KCB,BCL2L2,andBCL2genes.
Error bars represent mean±S.D. of triplicate samples
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KD cells (Figure 7c). Overall, these
results strongly provide evidence that the TNF-a-induced
apoptosis in AMPK-a1
KD cells is associated with expressions
of pro- or anti-apoptotic genes related to NF-kB transcrip-
tional activity.
Discussion
Our experiments demonstrate that AMPK-a1 critically
regulates TLR4-mediated signaling pathway through the
activation of TAK1. We found that autoinhibitory domain of
AMPK-a1 interacts with theN-terminus of TAK1.The masking
of autoinhibitory domain of AMPK-a1 seems to be critically
associated with the activation of AMPK-a1 by TAK1,
30 which
led usto speculatethat AMPK-a1 might regulate the activity of
TAK1 through the intermolecular interaction. In terms of the
activity of AMPK-a1, the inhibition of AMPK-a1 activity with a
pharmacological compound, compound C, revealed a dra-
matic reduction in NF-kB and AP-1 activities, and production
of proinﬂammatory cytokines, such as TNF-a, IL-6, and IL-1b,
in response to LPS stimulation. Moreover, we found that a
constitutive active form of AMPK-a1 signiﬁcantly augmented
these activities induced by LPS treatment, but not in a DN
form as AMPK-a1. These results suggest that AMPK-a1i s
functionally involved in TLR4-mediated signaling through the
molecular interaction with TAK1.
The TAK1 was originally identiﬁed as a TGF-b-activated
kinase.
1–3 The TAK1 is involved in distinct cellular signals
such as Wnt, bone morphogenetic protein, activin, and TGF-
b-signalingpathways.
3,31,32Inaddition,TAK1hasamajorrole
in both innate and adaptive immunity pathways.
5–8 We found
that, in AMPK-a1-knockdown THP-1 cells, TAK1 phosphor-
ylation was markedly reduced in response to LPS stimulation
when compared with that of wt THP-1 cells. In agreement with
previousreports,
22–24phosphorylationsofJNK,p38, andAKT
were impaired in LPS-treated AMPK-a1-knockdown THP-1
cells, indicating that AMPK has an important role in promoting
p38, JNK, AKT activations. Furthermore, DNA-binding activ-
ities of p65, p50, c-Fos, and c-Jun were markedly reduced in
AMPK-a1-knockdown THP-1 cells. In AMPK-a1-knockdown
THP-1 cells, dramatic reductions in TNF-a, IL-6, and IL-1b
could be detected in response to LPS stimulation. Moreover,
microarray and qRT-PCR analysis targeted to NF-kB-depen-
dent genes critically revealed marked reductions of the
expression of these genes in AMPK-a1-knockdown THP-1
cells after LPS treatment. These results strongly support the
hypothesis that AMPK-a1 is critically required for TLR4-
mediated signaling, thus leading to activation of NF-kB and
AP-1, and thereby regulating expressions of NF-kB-depen-
dent genes.
To verify the functional role of AMPK-a1 capable of
regulating TAK1 activity, we conﬁrmed the effects in another
system, TFN-a-induced apoptosis. Previous studies have
shown that TAK1 has a protective role against TNF-a-induced
apoptosis through the activation of NF-kB.
3,4 Interestingly,
AMPK-a1-knockdown cells were highly sensitive to TNF-a-
induced apoptosis along with a marked reduction in the levels
of NF-kB-dependent genes as compared with those of wt
THP-1 cells. When we analyzed the expression of anti-
apoptotic genes and pro-apoptotic genes in AMPK-a1-
knockdown or wt THP-1 cells after TNF-a treatment,
furthermore, marked inductions of pro-apoptotic genes could
be detected, whereas signiﬁcant reductions in anti-apoptotic
genes could be detected in AMPK-a1-knockdown THP-1
cells. These results were similar to that of TNF-a-induced
apoptosis in TAK1
 / MEF cells. Therefore, the obtained
results support a pivotal role of AMPK-a1 as an upstream
kinase of TAK1, which eventually lead to express NF-kB-
dependent genes related in the protection to TNF-a-induced
apoptosis.
Although it is not completely understood as how TAK1
activity is biochemically regulated, its activation seems to
require TAK1-binding proteins such as TAB1, TAB2, and
TAB3. In addition, a plausible model about how to activate
TAK1 in innate signaling has been proposed in a recent
report.
6 Binding of IL-1b to IL-1R or LPS to TLR4 causes
recruitment of adopter proteins such as MyD88, IRAK, and
TRAF6tothereceptor.TheTRAF6inturncatalyzessynthesis
of K63-linked polyubiquitin chains. The polyubiquitin chains
actsasascaffoldmotiftorecruittheTAK1andIKKcomplexes
through binding to the regulatory subunits TAB2 and NEMO,
respectively. Recruitment of the kinase complexes facilitates
autophosphorylation of TAK1 and subsequent phosphoryla-
tion of IKKb by TAK1, thus leading to IkB degradation and
subsequent activation of NF-kB. Our data propose a potential
possibility that TAK1 activity in both TLR4- and TNF-a-
mediatedsignalingpathwaymayberegulatedbyAMPK-a1as
an upstream kinase of TAK1. Taken together, our data are
summarizedinFigure8.BindingofLPSderivedfrom bacterial
components to TLR4 initiates intracellular-signaling cas-
cades, initially leading to the recruitment of adaptor molecules
such as MyD88, IRAKs, and Mal proteins. Two critical events
for the activation of TAK1 may occur in the middle of signaling
cascades. Upon the TLR4 stimulation, the activation of
AMPK-a1 is simultaneously induced by LKB1 and Ca
2þ-
calmodulin-dependent protein kinase, and then activated
AMPK-a1 can induce activation of JNK/p38MAPK pathway,
thereby inducing activations of AP-1 components such as
c-Jun and c-fos. Simultaneously, activated AMPK-a1 speci-
ﬁcally interacts with TAK1 through the molecular interaction
between N-terminus of TAK1 and autoinhibitory domain of
AMPK-a1, and subsequently induces the phosphorylation of
TAK1 for the activation. In turn, the activated TAK1 subse-
quently induces the phosphorylation of IKKb, leading to IkB
degradation and activation of NF-kB. Nevertheless, the
existence of other upstream kinases capable of inducing
TAK1 activation and the reciprocal regulation between TAK1
and AMPK-a1 is not completely ruled out. Therefore, future
studies elucidating the speciﬁc molecular mechanism may
contribute towards more detailed understanding on the
functional roles played by TAK1 as a key element kinase in
different innate signaling pathways.
Materials and Methods
Cells and antibodies. The HEK 293 cells (human kidney embryonic cells)
were purchased from American Type Culture Collection (ATCC, Manassas,
VA, USA) and maintained in DMEM medium (Invitrogen Corporation, Carlsbad,
CA, USA) containing 10% FBS, 2mM L-glutamine, 100 unit/ml of penicillin, 100mg/ml
streptomycin, and 5 10
 5 M b-mercaptoethanol. The THP-1 cells (human
monocytic cells) were purchased from ATCC and maintained in RPMI medium
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of penicillin, 100mg/ml streptomycin, and 5 10
 5 M b-mercaptoethanol.
TAK1
 / MEF cells were cultured in DMEM medium (Invitrogen Corporation)
containing 5% FBS, 2mM L-glutamine, 100 unit/ml of penicillin, and 100mg/ml
streptomycin and 5 10
 5 M b-mercaptoethanol.
3 Antibodies used were
anti-pho-AMPK-a1 (Ser485), anti-pho-AMPK-a1 (Thr172/Thr174), anti-pho-TAK1,
anti-TAK1, anti-IkBa, anti-pho-p38, anti-p38, anti-pho-JNK, anti-JNK, anti-pho-AKT,
anti-AKT, anti-Myc, anti-Flag, anti-GAPDH (Cell Signaling, Beverly, MA, USA), and
anti-AMPK-a1 antibodies (Abcam, Cambridge, MA, USA).
Generation of AMPK-a1-knockdown or TAK1-knockdown THP-1
cells. Lentiviral particles containing shRNA-targeted human AMPK-a1 (sc-29673-V)
or human TAK1 (sc-36606-V) were purchased from Santa Cruz Biotechnology Inc.
(Santa Cruz, CA, USA) 2 10
 7 cells were cultured in a 24-well plate and infected
with each rentiviral particle according to the manufacturer’s protocol. Cells were
cultured in puromycin (4mg/ml)-containing medium for 2 weeks to select stable clones.
Luciferase reporter assay. The THP-1 cells (2 10
 5) grown on 12-well
plates were transiently transfected using Neon transfection system (Invitrogen,
Carlsbad, CA, USA), according to the respective manufacturer’s instructions, with
either NF-kB-dependent reporter construct pBIIx-luc or AP-1-dependent reporter
construct AP-1-luc with Renilla luciferase vector (Promega Corporation, Madison,
WI, USA).
33 Total DNA concentration in each experiment was maintained by
adding the appropriate empty vector to the DNA mixture. Typically 24h after
transfection, cells were lyzed and luciferase activity was measured using the dual
luciferase assay kit (Promega).
Measurement of cytokines. Wt THP-1 cells were transiently transfected
using Neon transfection system, according to the respective manufacturer’s
instructions, with mock, WT hAMPK-al, hAMPK-a1 (D159A), and hAMPK-a1
(T174D) vectors. Cells were stimulated with or without LPS (10ng/ml) for 9h, and
subsequently supernatants were harvested. Levels of TNF-a, IL-1b, and IL-6 were
measured in the supernatants, according to the manufacturer’s protocol (R&D
Systems, Minneapolis, MN, USA). Wt THP-1 and AMPK-a1
KD THP-1 cells were
stimulated with or without LPS (10ng/ml) for 9h, and then supernatants were
harvested. Levels of TNF-a, IL-1b, and IL-6 were measured in the supernatants,
according to the manufacturer’s protocol (R&D Systems).
p65/p50 (NF-kB) and c-Fos/c-Jun (AP-1) DNA-binding assay by
enzyme-linked immunosorbent assay. Nuclear proteins from transfec-
tants treated with or without LPS were prepared with CelLyticTM NuCLEARTM
Extraction kit in accordance with the manufacturer’s protocol (Sigma-Aldrich,
St. Louis, MO, USA). Activities of transcription factors, p65, p50, c-Jun, and c-Fos,
were determined with TransAM NF-kB or AP-1 transcription factor assay kit
according to the manufacturer’s instructions (Active Motif North America, Carlsbad,
CA, USA).
4,34 Brieﬂy, a speciﬁc double-stranded DNA sequence containing the
NF-kB or AP-1 response element was immobilized on a 96-well plate, and the
binding of the activated p65 or p50 to the NF-kB response element and c-fos or
c-Jun to the AP-1 response element was achieved by incubating nuclear extracts
in the presence of binding buffer. The interaction between the protein–DNA
complexes was detected by the addition of speciﬁc antibodies against p65, p50,
c-fos, or pho-c-Jun. Addition of a secondary antibody conjugated to horseradish
peroxidase provided a sensitive colorimetric readout at 450nm.
Plasmids and mutagenesis. The pcDNA3-Flag-hAMPK-a1 wt was kindly
provided by Dr. SJUm.
35 The pcDNA3-Myc-hTAK1 wt was generated by PCR,
using HeLa cDNA library as a template, and inserted into pcDNA3. Myc-TAK1
mutants, Myc-TAK1 1–500, Myc-TAK1 1–400, Myc-TAK1 1–300, Myc-TAK1 1–200,
and Myc-TAK1 1–100, were generated by PCR, using Myc-TAK1 wt as a template,
and inserted into pcDNA3. The Flag-AMPK-a1 mutants, Flag-AMPK-a1 (1–312)
and Flag-AMPK-a1 (1–392), were generated by PCR, using Flag-AMPK-a1w ta s
a template, and inserted into pcDNA3. Flag-AMPK-a1 mutants, Flag-AMPK-a1
(D159A) and Flag-AMPK-a1 (T174D) were generated using the MORPH plasmid
DNA mutagenesis kit supplied by 50-30 Inc. (Boulder, CO, USA).
36,37
Immunoprecipitation and western blot analysis. Transfected HEK
293 cells with appropriate expression vectors were lysed in a lysis buffer
containing 150mM NaCl, 20mM Tris-HCl, pH 7.5, 10mM EDTA, 1% Triton X-100,
1% deoxycholate, 1.5% aprotinin, and 1mM phenylmethylsulfonyl ﬂuoride. Cellular
debris was removed by centrifugation. Co-immunoprecipitation procedures were
followed as previously described.
4,36 For immunoprecipitation and western blotting,
we used anti-Myc and anti-Flag antibodies (Sigma-Aldrich). The proteins were
detected by the enhanced chemiluminescence system (Amersham Pharmacia
Biotech, Amersham, UK). For endogenous immunoprecipitation, THP-1 cells were
treated with or without LPS (100ng/ml) for 45min. Cells were extracted and
immunoprecipitated with anti-TAK1 antibody. The interaction was detected by
western blotting with anti-AMPK-a1 antibody. The same lysates were veriﬁed with
anti-TAK1 antibody.
In vitro kinase assay for TAK1 and AMPK-a1. Wt THP-1, AMPK-
a1
KD, and TAK1
KD THP-1 cells were treated with or without LPS (100ng/ml) for
different times. The kinase assay for TAK1 and AMPK-a1 was performed by
c-TAK1 Kinase Assay kit (U-TRF#17, PerkinElmer, Branchburg, NJ, USA) and
AMPK-a1 Kinase assay kit (U-TRF#12, PerkinElmer) in accordance with the
manufacturer’s protocol.
Measurement of caspase-3, caspase-8, and caspase-9 activities.
Wt THP-1 and AMPK-a1
KD THP-1 cells were cultured in RPMI medium containing
2% FBS. Cells were treated with or without TNF-a (100ng/ml) for different times,
harvested, and washed twice with PBS. Caspase-3, caspase-8, and caspase-9
activities were measured using the CaspACE kit (Promega) according to the
manufacture’s instructions.
33
Figure 8 Schematic model showing role of AMPK-a1 as an upstream kinase of
TAK1 in TLR4-mediated signaling pathway. Binding of LPS derived from bacterial
components to TLR4 initiates intracellular signaling cascades, initially leading to the
recruitment of adapter molecules such as MyD88, IRAKs, and Mal proteins. Two
critical events for the activation of TAK1 may occur in the middle of signaling
cascades. Upon TLR4 stimulation, the activation of AMPK-a1 is simultaneously
induced by LKB1 and Ca
2þ-calmodulin-dependent protein kinase, and then
activated AMPK-a1 can induce activation of JNK/p38MAPK pathway, thereby
inducing activations of AP-1 components such as c-Jun and c-fos. Simultaneously,
activated AMPK-a1 speciﬁcally interacts with TAK1 through the molecular
interaction between N-terminus of TAK1 and autoinhibitory domain of AMPK-a1,
andthenAMPK-a1andTAK1reciprocallyinducesphosphorylationsofTAK1forthe
activation. In turn, the activated TAK1 subsequently induces the phosphorylation of
IKKb, leading to IkB degradation and activation of NF-kB. Subsequently,
proinﬂammatory cytokine genes such as TNF-a, IL-1b, and IL-6 are expressed
AMPK-a1 as an activating kinase of TAK1
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Cell Death and DiseaseDNA fragmentation analysis. Cells were homogenized in 1ml of lysis
buffer (20mM Tris-HCl, pH 8.0, 5mM EDTA, 0.5% SDS, 0.5mg/ml proteinase K)
and incubated for 15h at 421C under constant agitation. Proteins were then
precipitated with 6M NaCl and centrifuged at 2500 g at 41C for 15min.
Supernatants containing genomic DNA were then treated with RNase A at 371C
for 30min. The genomic DNA was precipitated for 3h at  701C with 2.5
volumes of 100% ethanol and 0.2 volumes of 3M sodium acetate. Samples were
then centrifuged at 20800 g at 41C for 30min. The resulting pellets were
washed with 70% ethanol and resuspended in 40ml of nuclease-free water.
Genomic DNA extracts (10–20ml) were run on 1.8% agarose gels and visualized
under UV illumination.
Cell cycle and apoptosis analysis. Wt THP-1 and AMPK-a1
KD THP-1
cells were cultured in RPMI medium containing 2% FBS. Cells were treated with or
without TNF-a (100ng/ml) for different times, harvested, and washed twice with
PBS. The cells were stained with FITC Annexin V Apoptosis Detection Kit
(BD Biosciences, San Jose, CA, USA) or BD Cycletest Plus-DNA Reagent kit
(BD Biosciences) in accordance with the manufacturer’s protocol. Samples were
analyzed with FACSCalibur system and then apoptotic cell death was determined
with CellQuest software (Becton Dickinson, San Jose, CA, USA) or Modﬁt LT 3.0
software (Becton Dickinson).
Microarray analysis. Total RNA was extracted using Trizol (Invitrogen Life
Technologies, Carlsbad, CA, USA) and puriﬁed using RNeasy columns (Qiagen,
Valencia, CA, USA) according to the manufacturers’ protocol. After processing
with DNase digestion, and clean-up procedures, RNA samples were quantiﬁed,
aliquoted, and stored at  801C until use. For quality control, RNA purity and
integrity were evaluated by denaturing gel electrophoresis, OD 260/280 ratio, and
analyzed on Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA, USA).
Total RNA was ampliﬁed and puriﬁed using the Ambion Illumina RNA ampliﬁcation
kit (Ambion, Austin, TX, USA) to yield biotinylated cRNA according to the
manufacturer’s instructions. Brieﬂy, 550ng of total RNA was reverse-transcribed to
cDNA using a T7 oligo(dT) primer. Second-strand cDNA was synthesized, in vitro
transcribed, and labeled with biotin-NTP. After puriﬁcation, the cRNA was
quantiﬁed using the ND-1000 Spectrophotometer (NanoDrop, Wilmington,
NC, USA). Typically, 750ng of labeled cRNA samples were hybridized to each
humanHT-12 expression v.4 bead array for 16–18h at 581C, according to the
manufacturer’s instructions (Illumina Inc., San Diego, CA, USA). Detection of array
signal was carried out using Amersham ﬂuorolink streptavidin-Cy3 (GE Healthcare
Bio-Sciences, Little Chalfont, UK) following the bead array manual. Arrays were
scanned with an Illumina bead array Reader confocal scanner according to the
manufacturer’s instructions. For raw data preparation and statistical analysis, the
quality of hybridization and overall chip performance were monitored by visual
inspection of both internal quality control checks and the raw scanned data. Raw
data were extracted using the software provided by the manufacturer (Illumina
GenomeStudio v2009.2 (Gene Expression Module v1.5.4)). Array data were
ﬁltered by detection of P-value o0.05 (similar to signal to noise) in at least 50%
samples (we applied a ﬁltering criterion for data analysis; higher signal value was
required to obtain a detection P-value o0.05). Selected gene signal value was
transformed by logarithm and normalized by quantile method. The comparative
analysis between test sample and control sample was carried out using fold
change. Hierarchical cluster analysis was performed using complete linkage and
Euclidean distance as a measure of similarity. GO-ontology analysis for signiﬁcant
probe list was performed using PANTHER (http://www.pantherdb.org/panther/
ontologies.jsp), using text ﬁles containing Gene ID list and accession number of
illumina probe ID. Gene Set Enrichment Analysis was performed to check whether
the a priori deﬁned set of genes shows a differential pattern in both the biological
process and the molecular function states. One-tail Fisher Exact was adopted to
measure the gene enrichment in annotation terms. All the data analysis and
visualization of differentially expressed genes was conducted using R 2.4.1(www.
r-project.org).
Gene expression analysis by qPCR. Isolation of total RNA, and cDNA
synthesis, were performed following the protocols provided along with the kit
(Qiagen). For qPCR analysis, qPCR primers were purchased from Qiagen: IL-8
(PDH 00568A), TNF (PDH 00341E), CD44 (PDH 00114A), CCL5 (PDH 00703A),
NF-KB1 (PDH 00204E), NF-KB1A (PDH 00170E), NF-KB1E (PDH 01810E),
RELB (PDH 00287A), IER3 (PDH 10008E), REL (PDH 00101B), BCL3 (PDH
02009C), IL-1B (PDH 00171B), PTEN (PDH 00327E), LTA (PDH 00337E),
MAGED1 (PDH 01965A), TNFRFS21 (PDH 00262A), SGK1 (PDH 00387E),
PI3KCB (PDH 00789A), BCL2L2 (PDH 00081E), and BCL2 (PDH 00079B). The
qRT-PCR analysis was performed using Roter-GeneQ (Qiagen) according to the
manufacturers’ protocol.
Statistical analysis. Data were presented as mean values±S.D. as
indicated and analyzed using Student’s two-tailed t-test. A P-value o0.05 was
considered to be statistically signiﬁcant.
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